Ortho Evra (Evra)

a combination transdermal contraceptive patch with a contact surface area of 20 cm2. It contains 6 mg norelgestromin and 0.75 mg ethinyl estradiol; was indexed to norelgestromin (2002-2006)

Also Known As:

Networked: 15 relevant articles (0 outcomes, 8 trials/studies)

Drug Context: Research Results

Experts

1.	Jick, Susan S: 3 articles (05/2010 - 02/2007)
2.	Davies, Alun H: 2 articles (04/2021 - 12/2020)
3.	Heatley, Francine: 2 articles (04/2021 - 12/2020)
4.	Hagberg, Katrina W: 2 articles (05/2010 - 01/2010)
5.	Kaye, James A: 2 articles (05/2010 - 01/2010)
6.	Ahern, T: 1 article (06/2022)
7.	Keohane, C R: 1 article (06/2022)
8.	Tawfick, W: 1 article (06/2022)
9.	Twyford, M: 1 article (06/2022)
10.	Walsh, S R: 1 article (06/2022)

Related Diseases

1.	Ulcer 01/01/2023 - "Both trials randomised participants to endovenous treatment and compression or compression alone, however the compression alone group in the EVRA trial received deferred endovenous treatment (after ulcer healing or from six months). " 01/01/2023 - "The ESCHAR (effect of surgery and compression on healing and recurrence) and EVRA (early venous reflux ablation) trials demonstrated that surgical correction of superficial venous reflux reduced ulcer recurrence, resulted in faster healing times (EVRA), and was proved cost-effective. " 04/01/2021 - "The management of venous leg ulceration post the EVRA (early venous reflux ablation) ulcer trial: Management of venous ulceration post EVRA." 12/01/2020 - "One-year outcomes from the Early Venous Reflux Ablation (EVRA) randomized trial showed accelerated venous leg ulcer healing and greater ulcer-free time for participants who are treated with early endovenous ablation of lower extremity superficial reflux. "
2.	Varicose Ulcer (Ulcer, Venous) 06/10/2022 - "If AA is found to be superior to TIRS, then this would suggest that all patients undergoing ablation in the management of venous ulcers should have their superficial reflux fully treated, building on the evidence of the EVRA trial. " 12/01/2018 - "Results of the EVRA trial will be a game-changer for the management of every venous ulcer."
3.	Leg Ulcer 02/01/2019 - "The EVRA Trial: New Hope for People with Venous Leg Ulcers?" 12/01/2020 - "One-year outcomes from the Early Venous Reflux Ablation (EVRA) randomized trial showed accelerated venous leg ulcer healing and greater ulcer-free time for participants who are treated with early endovenous ablation of lower extremity superficial reflux. "
4.	Venous Thromboembolism 05/01/2010 - "ORTHO EVRA and venous thromboembolism: an update." 01/01/2010 - "Concern has been raised that the risk of venous thromboembolism (VTE) in users of the ORTHO EVRA patch is higher compared to users of oral contraceptives (OCs). " 01/01/2010 - "Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism."
5.	Weight Gain 04/01/2005 - "Eleven girls (39%) discontinued Ortho Evra (three lost health insurance, three because of application site reactions, two found patch application schedule difficult to remember, two desired pregnancy, two because of nausea, one because of perceived weight gain). " 08/26/2008 - "As weight gain is one of the most frequently cited reasons for not using and for discontinuing hormonal contraceptives, in an open-label, single-arm, multicentre clinical study we evaluated the effect of the ethinylestradiol/norelgestromin contraceptive patch (EVRA, Janssen-Cilag International, Belgium) on body composition using bioelectrical impedance analysis (BIA). "

Related Drugs and Biologics

1.	Contraceptive Agents (Contraceptives)
2.	Ethinyl Estradiol (Estinyl)
3.	Oral Contraceptives
4.	Levonorgestrel (Plan B)
5.	norelgestromin (LNGO)
6.	drospirenone and ethinyl estradiol combination (Yasmin)
7.	norgestimate